REMEGEN (09995): Wang Weidong re-elected as Chairman of the Board of Directors.

REMEGEN (09995) announced that at the annual shareholders' meeting, Mr. Wang Weidong, Dr. Fang Jianmin, Mr. Wen Qingkai, and Ms. Fang Yi were elected or re-elected as executive directors of the third board of directors; Dr. Wang Liqiang was re-elected as a non-executive director of the third board of directors; Mr. Song Xiliang, Mr. Huang Guobin, and Mr. Chen Yunjin were elected or re-elected as independent non-executive directors of the third board of directors. The company held a staff representative assembly on June 16, 2026. Through democratic elections, Mr. Wang Yuxiao was elected as a staff representative director (executive director) of the third board of directors. Mr. Wang Yuxiao's term of office will be three years from the date of the annual shareholders' meeting, until the end of the term of the third board of directors. At the first meeting of the third board of directors held on June 16, 2026, it was decided that Mr. Wang Weidong was re-elected as the chairman of the third board of directors; Dr. Fang Jianmin was re-elected as the CEO of the company. The terms of office for the above positions will be three years from the date of the annual shareholders' meeting, until the end of the term of the third board of directors.